Estrogen replacement therapy: Indications, contraindications, and agent selection
- 1 December 1989
- journal article
- review article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 161 (6) , 1832-1841
- https://doi.org/10.1016/s0002-9378(89)80003-1
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Does Calcium Supplementation Prevent Postmenopausal Bone Loss?New England Journal of Medicine, 1987
- Biologic Effects of Transdermal EstradiolNew England Journal of Medicine, 1986
- Post‐Menopausal Osteoporosis: A practical approach to its preventionActa Obstetricia et Gynecologica Scandinavica, 1986
- A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart DiseaseNew England Journal of Medicine, 1985
- Postmenopausal Estrogen Use, Cigarette Smoking, and Cardiovascular Morbidity in Women over 50New England Journal of Medicine, 1985
- Relative Contributions of Aging and Estrogen Deficiency to Postmenopausal Bone LossNew England Journal of Medicine, 1984
- Effect of Estrogen/Progestin Potency on Lipid/Lipoprotein CholesterolNew England Journal of Medicine, 1983
- Effect of the Fluoride/Calcium Regimen on Vertebral Fracture Occurrence in Postmenopausal OsteoporosisNew England Journal of Medicine, 1982
- Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement TherapyNew England Journal of Medicine, 1981
- Estrogen Use in Postmenopausal Women — Costs, Risks, and BenefitsNew England Journal of Medicine, 1980